financetom
Business
financetom
/
Business
/
Brazil's Carrefour swings to profit in first quarter
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Brazil's Carrefour swings to profit in first quarter
May 7, 2024 8:35 PM

SAO PAULO (Reuters) -Carrefour Brasil, which is controlled by France's Carrefour, reported a net profit of 39 million reais ($7.7 million) for the first quarter, reversing losses in the same period last year, as higher food inflation expanded its profits.

On an adjusted basis, it also swung back to the black with a 52-million-real net profit, although this profit came in below the forecast of 137.4 million reais from analysts polled by LSEG.

Carrefour Brasil had already disclosed its first-quarter sales figures in late April, which rose 2.5% year-on-year, with hybrid wholesale unit Atacadao, which accounts for nearly 70% of the group activity, growing sales by 6.6%.

"We have seen a recovery of food inflation to positive levels, which obviously had positive effects in our prices and volumes," CEO Stephane Maquaire told journalists on Tuesday.

He added that recent food inflation trends have triggered improved sales by Atacadao to corporate customers, mainly smaller grocery stores, which had reduced their purchases due to financial pressures from lower margins.

"Merchants have been recovering their dynamics of buying to replenish stocks," he said, adding this dynamic is just "in the beginning".

About Carrefour Brasil's retail segment, which saw sales slip more than 10% in the quarter, Maquaire said management has been starting to test lower prices for some basic products aiming to increase the unit performance.

Carrefour Brasil said its consolidated adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) rose 36.6% to 1.42 billion reais, slightly above analysts forecast of 1.33 billion reais.

Adjusted EBITDA margins rose to 5.7% from 4.3% a year earlier.

Maquaire also said the company temporarily closed seven stores of almost 100 owned in Brazil's southernmost state of Rio Grande do Sul, where heavy rains have caused deadly floods in recent days.

He added the company decided to freeze all prices in Rio Grande do Sul until the end of May.

($1 = 5.0744 reais)

(Reporting by Andre Romani; Editing by Steven Grattan and Lincoln Feast.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Delta Issues Downbeat Fourth-Quarter Earnings Outlook Following Mixed Quarterly Results
Delta Issues Downbeat Fourth-Quarter Earnings Outlook Following Mixed Quarterly Results
Oct 10, 2024
09:24 AM EDT, 10/10/2024 (MT Newswires) -- Delta Air Lines ( DAL ) issued a weak fourth-quarter earnings outlook amid expectations for subdued travel demand around the US Presidential elections in November, as the air carrier's bottom line fell short of market estimates in the prior three-month period while revenue beat Wall Street forecasts. The airline anticipates adjusted earnings to...
Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details
Indivior Cuts 2024 Outlook As Competition And Market Pressures Weigh On SUBLOCADE: Details
Oct 10, 2024
Indivior PLC ( INDV ) shares are trading lower after the company reported preliminary third-quarter revenue results and cut its FY24 net revenue guidance below estimates. The company expects third-quarter net revenue of $302 million – $309 million versus the consensus of $289.37 million. Also, Indivior ( INDV ) trimmed its FY24 net revenue outlook to $1.125 billion – $1.165 billion (consensus $1.185 billion) from $1.15 billion –...
Mirum Pharmaceuticals Says Volixibat Gets FDA Breakthrough Therapy Designation in Cholestatic Pruritus
Mirum Pharmaceuticals Says Volixibat Gets FDA Breakthrough Therapy Designation in Cholestatic Pruritus
Oct 10, 2024
09:25 AM EDT, 10/10/2024 (MT Newswires) -- Mirum Pharmaceuticals ( MIRM ) said Thursday that volixibat has received breakthrough therapy designation from the US Food and Drug Administration as a potential treatment for cholestatic pruritus related to primary biliary cholangitis. The company said the designation is based on the interim analysis of a phase 2b study that demonstrated statistically significant...
Starboard seeks probe after former Pfizer execs pull support for its campaign
Starboard seeks probe after former Pfizer execs pull support for its campaign
Oct 10, 2024
(Reuters) - Starboard Value has asked Pfizer to set up a special committee to investigate allegations that two of its former senior executives were forced to publicly declare support for CEO Albert Bourla, the hedge fund said on Thursday. Former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio, who were reportedly helping the activist investor in its plan to push...
Copyright 2023-2026 - www.financetom.com All Rights Reserved